In this issue

About Face - Facebook makes billions helping advertisers reach its users.

Death by a Thousand Clicks - The U.S. government claimed that electronic health records would lead to safer, cheaper health care: 10 years and $36 billion later, the system is a mess and more...

Q+A Kevin Sneader

Recent revelations have subjected consulting giant McKinsey to awkward scrutiny. Its leader describes what could change at the influential and secretive firm.

8 mins

Extreme Measures

Simplehuman, the high-end housewares maker, takes product testing very seriously. The obsession appears to be paying off.

3 mins

China's Electric-Car Showdown

Tesla, General Motors, and Volkswagen are betting big on the world’s largest market for electric vehicles. But the country’s domestic manufacturers, like BJEV, have a huge head start.

5 mins

Is 42 The Answer?

A billionaire disrupter of the French telecom market had a radical idea: Build a computer programming school that has no books, no teachers, and no classes. Oh, and make it free. Six years in, has it worked?

4 mins

Betting On Tech's Building Blocks

The cloud-computing boom has seeded a crop of fast- growing companies that cater to software coders. How investors can profit from the pursuit of API-ness.

4 mins

Taking Back Fifth Avenue

A $250 million revamp of Saks’ Manhattan flagship is the tip of the spear in the hypercompetitive department store wars.

5 mins

About Face

MARK ZUCKERBERG’S DORM-ROOM CREATION is worth half a trillion dollars, has 2.3 billion regular users, and dominates its corner of the online advertising industry because its ads are so effective. Now Facebook is under attack from regulators, competitors, and privacy advocates —even as its growth slows. The challenge: mollify its critics without destroying its business model. Fortune’s inside look at an impossible dilemma.

10+ mins

Death By A Thousand Clicks

THE U.S. GOVERNMENT CLAIMED that turning American medical charts into electronic records would make health care better, safer, and cheaper. Ten years and $36 billion later, the system is an unholy mess. Inside a digital revolution gone wrong.

10+ mins

Finding New Cures In Old Drugs

Data-savvy scientists like DANIEL COHEN of Pharnext are using ARTIFICIAL INTELLIGENCE to figure out how to turn combinations of existing drugs into promising new therapies. Can they unclog Big Pharma’s drug pipeline?

10+ mins

Racing In The Streets

Singapore’s Grab And Indonesia’s Go-jek Started Out As Scrappy Taxi Services. Now They’re Expanding Into Banking, Groceries, And More—and Jockeying To Offer The Top “super-app” In Some Of The World’s Fastest-growing Economies.

10+ mins

Read all stories from Fortune US

Fortune US Magazine Description:

FORTUNE covers the entire field of business, including specific companies and business trends, tech innovation prominent business leaders, and new ideas shaping the global marketplace. FORTUNE is particularly well known for its exceptionally reliable annual rankings of companies. FORTUNE furthers understanding of the economy, provides implementable business strategy, and gives you the practical knowledge you need to maximize your own success.